
Basia Medical Inc.
Basia Medical is a women’s health technology company developing AI-guided medical devices that will make gynecologic care simpler, more comfortable, and more accessible.

Basia Medical is a women’s health technology company developing AI-guided medical devices that will make gynecologic care simpler, more comfortable, and more accessible.

Clinician -founded digital health company at the intersection of women’s health, behavioural science and clinical intelligence. Their work is grounded in validated clinical frameworks to reach women where they are,

37c Systems is developing a compact tabletop device that warms body-safe materials to precise body temperature, 37 degrees Celsius, and sanitizes them via UV-C light in minutes. One device. Two

Scopia Surgical develops planning and navigation technologies for surgical oncology and general surgery. One of their core focus is woman pelvic surgery including hysterectomies, endometriosis, rectal cancer and fibroids.

Gyneview is a self-retaining vaginal retractor enabling clinicians to have clear visualization of the surgical field during a repair. Gyneview is the only device on the market that has a

EndoID™ is a first-in-class blood-based ELISA test developed by SYNG Pharmaceuticals Inc. to support non-invasive triage of women suspected of endometriosis. They also have an AI-powered digital cognitive assessment that

SPM Therapeutics is developing a new class of therapeutics based on natural MARESIN compounds that resolve inflammation at its source. Its patented lead candidate, MaR102-TL, is the first therapy designed

Sleaks design washable bladder leak underwear that looks and feels like everyday underwear, but with the protection and absorbency of disposables. Their patented technology features a waterproof pouch and a

Elle Santé uses technology to deliver personalized, AI-driven and cycle-aware care plans that help women manage pelvic health conditions with daily support, symptom tracking, and access to expert guidance, all

EndoDiagnosis Inc. is closing the diagnostic gap for endometriosis, reducing the time from over eight years to less than an hour with its Tier 1 ENDOSURE TEST. The company provides
We use essential cookies to make this site work. With your permission, we'd also like to use analytics cookies to understand how people use the site, and marketing cookies to measure our outreach. You can change your choice any time. Privacy policy
Choose which cookies you allow. Essential cookies are always on because the site can't work without them.
Keep the site secure, remember your cookie choice and make core features work.
Help us understand which pages are visited and how people find us (Google Analytics). Data is aggregated.
Measure our campaigns and show relevant content on other platforms (e.g. Google Ads, LinkedIn, Meta).